Have your own idea? Try our Stock Screener
Chinese (SSE) Drug Retail Industry Analysis
UpdatedAug 10, 2025
DataAggregated Company Financials
Companies9
- 7D-1.1%
- 3M-3.3%
- 1Y22.2%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 1.1%, driven by LBX Pharmacy Chain declining 4.7%. This takes the industry's 12 month performance to a gain of 21%. Earnings are forecast to grow by 22% annually.
Industry Valuation and Performance
Has the Chinese Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 10 Aug 2025 | CN¥92.2b | CN¥120.4b | CN¥3.3b | 31.1x | 28.3x | 0.8x |
| Tue, 08 Jul 2025 | CN¥93.6b | CN¥120.4b | CN¥3.3b | 31.5x | 28.7x | 0.8x |
| Thu, 05 Jun 2025 | CN¥97.8b | CN¥120.4b | CN¥3.3b | 33.2x | 30x | 0.8x |
| Sat, 03 May 2025 | CN¥96.7b | CN¥120.6b | CN¥3.5b | 26.5x | 27.4x | 0.8x |
| Mon, 31 Mar 2025 | CN¥88.0b | CN¥121.0b | CN¥3.9b | 20.6x | 22.5x | 0.7x |
| Wed, 26 Feb 2025 | CN¥83.8b | CN¥121.0b | CN¥3.9b | 19.4x | 21.5x | 0.7x |
| Fri, 24 Jan 2025 | CN¥80.1b | CN¥121.0b | CN¥3.9b | 18.4x | 20.5x | 0.7x |
| Sun, 22 Dec 2024 | CN¥92.7b | CN¥121.0b | CN¥3.9b | 21.3x | 23.7x | 0.8x |
| Tue, 19 Nov 2024 | CN¥89.3b | CN¥121.0b | CN¥3.9b | 20.3x | 22.9x | 0.7x |
| Thu, 17 Oct 2024 | CN¥80.7b | CN¥119.6b | CN¥4.3b | 18.1x | 18.7x | 0.7x |
| Sat, 14 Sep 2024 | CN¥66.6b | CN¥119.6b | CN¥4.3b | 15.3x | 15.4x | 0.6x |
| Mon, 12 Aug 2024 | CN¥75.7b | CN¥118.4b | CN¥4.8b | 17.8x | 15.8x | 0.6x |
| Wed, 10 Jul 2024 | CN¥81.1b | CN¥118.4b | CN¥4.8b | 19.3x | 16.9x | 0.7x |
| Fri, 07 Jun 2024 | CN¥116.0b | CN¥118.4b | CN¥4.8b | 24.2x | 24.2x | 1x |
| Sun, 05 May 2024 | CN¥122.3b | CN¥117.4b | CN¥4.8b | 26.1x | 25.6x | 1x |
| Tue, 02 Apr 2024 | CN¥115.5b | CN¥114.8b | CN¥5.2b | 21.2x | 22.1x | 1x |
| Thu, 29 Feb 2024 | CN¥116.5b | CN¥115.9b | CN¥5.8b | 21x | 20x | 1x |
| Sat, 27 Jan 2024 | CN¥119.4b | CN¥116.0b | CN¥5.7b | 21x | 20.8x | 1x |
| Mon, 25 Dec 2023 | CN¥123.3b | CN¥116.0b | CN¥5.7b | 21.8x | 21.5x | 1.1x |
| Wed, 22 Nov 2023 | CN¥128.4b | CN¥116.0b | CN¥5.7b | 22.7x | 22.4x | 1.1x |
| Fri, 20 Oct 2023 | CN¥111.2b | CN¥113.6b | CN¥5.7b | 21.4x | 19.6x | 1x |
| Sun, 17 Sep 2023 | CN¥121.1b | CN¥113.6b | CN¥5.7b | 23.8x | 21.3x | 1.1x |
| Tue, 15 Aug 2023 | CN¥134.2b | CN¥109.7b | CN¥5.4b | 29x | 24.7x | 1.2x |
| Thu, 13 Jul 2023 | CN¥127.9b | CN¥109.7b | CN¥5.4b | 27.2x | 23.5x | 1.2x |
| Sat, 10 Jun 2023 | CN¥127.9b | CN¥109.7b | CN¥5.4b | 26.4x | 23.5x | 1.2x |
| Mon, 08 May 2023 | CN¥137.0b | CN¥109.2b | CN¥5.4b | 28.4x | 25.3x | 1.3x |
| Wed, 05 Apr 2023 | CN¥144.7b | CN¥94.8b | CN¥4.4b | 38.4x | 33.2x | 1.5x |
| Fri, 03 Mar 2023 | CN¥143.2b | CN¥90.3b | CN¥4.0b | 35.5x | 35.6x | 1.6x |
| Sun, 29 Jan 2023 | CN¥144.2b | CN¥90.3b | CN¥4.0b | 37x | 35.8x | 1.6x |
| Tue, 27 Dec 2022 | CN¥139.6b | CN¥90.3b | CN¥4.0b | 35.5x | 34.7x | 1.5x |
| Thu, 24 Nov 2022 | CN¥146.7b | CN¥90.3b | CN¥4.0b | 37.3x | 36.4x | 1.6x |
| Sat, 22 Oct 2022 | CN¥129.1b | CN¥85.6b | CN¥3.8b | 40.5x | 33.8x | 1.5x |
| Mon, 19 Sep 2022 | CN¥111.8b | CN¥85.6b | CN¥3.8b | 35.2x | 29.3x | 1.3x |
| Wed, 17 Aug 2022 | CN¥113.6b | CN¥80.8b | CN¥3.7b | 36.1x | 30.5x | 1.4x |
Price to Earnings Ratio
30.5x
Current Industry PE
- Investors are optimistic on the Chinese Drug Retail industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 28.6x which is higher than its 3-year average PE of 25.3x.
- The 3-year average PS ratio of 1.1x is higher than the industry's current PS ratio of 0.77x.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have declined 4.4% per year over the last three years.
- Meanwhile revenues for these companies have grown 14% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Chinese Drug Retail compare with similar industries?
| CN Market | 1.94% | |
| Consumer Staples | 1.14% | |
| Food and Staples Retail | 0.048% | |
| Drug Retail | -1.12% | |
| Food Distributors | 7.65% | |
| Big Box Super Stores | 3.37% | |
| Food Retail | 0.18% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 603233 DaShenLin Pharmaceutical Group | CN¥17.59 | 1.0% +CN¥193.6m | 33.0% | PE20.5x |